StonvexLoading…
StonvexStonvexStonvexCore line items from QXO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.73B | $6.84B | $4.65B | $1.92B |
Operating Income | $-251.90M | $-245.20M | $-175.70M | $-201.50M |
Net Income | $-227.10M | $-279.40M | $-189.20M | $-49.80M |
EPS (Diluted) | $-0.35 | $-0.63 | $-0.46 | $-0.19 |
Total Assets | $16.66B | $15.89B | $16.64B | $17.11B |
Total Liabilities | $6.50B | $6.18B | $6.82B | $7.20B |
Cash & Equivalents | $3.05B | $2.36B | $2.31B | $2.28B |
Free Cash Flow OCF − CapEx | $48.10M | $183.20M | $25.00M | $-157.40M |
Shares Outstanding | 710.80M | 674.50M | 674.30M | 671.60M |